Antihypertensive properties of the novel calcium antagonist (1S,2S)-2-[2-[[3-(2-Benzimidazolyl)propyl]methylamino]ethyl]-6-fluoro- 1,2,3,4-tetrahydro-1-isopropyl-2-naphthyl methoxyacetate dihydrochloride in rat models of hypertension. Comparison with verapamil

Arzneimittel-Forschung/Drug Research

Volumn 40, Issue 4, 1990, Pages 417-421

  Hefti, F ^a   Clozel, J P ^a   Osterrieder, W ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

(1S,2S) 2 2 3 (2 Benzimidazolyl)propyl methylamino ethyl 6 fluoro 1,2,3,4 tetrahydro 1 isopropyl 2 naphthyl methoxyacetate dihydrochloride, pharmacology; antihypertensive drugs; calcium antagonists; Ro 40 5967; verapamil

Indexed keywords

MIBEFRADIL; VERAPAMIL;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; CALCIUM ANTAGONISM; HYPERTENSION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

ANIMAL; ANTIHYPERTENSIVE AGENTS; BENZIMIDAZOLES; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; COMPARATIVE STUDY; DESOXYCORTICOSTERONE; HEART RATE; HYPERTENSION; MALE; MIBEFRADIL; NAPHTHALENES; RATS; RATS, INBRED SHR; RATS, INBRED STRAINS; TETRAHYDRONAPHTHALENES; VERAPAMIL;

EID: 0025216381     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)